There’s a huge demand for effective solutions in mental health (e.g. anxiety, depression, burn-out, PTSD, and other stress-related conditions) as well as related mind-body diseases that have no effective medication or treatment today.
Many patients receive medications for symptoms (e.g. antidepressants) that do not address the cause of the problem and have negative side effects. There are not enough therapists to answer the demand, and the therapy methods provided by the NHS (or other healthcare providers in other countries) are not effective enough for most of the patients who receive them, e.g. about 60% of people who received treatment for PTSD do not recover.
Several companies have developed some solutions (e.g. offering remote therapy on a monthly-subscription basis such as Cerebral, or digital apps such as Calm). Although these companies are now worth billions, they don’t provide effective scalable solutions for the majority of sufferers of depression, anxiety, IBS, etc.
Opportunity for Investors
We are offering an ethical and socially responsible investment opportunity in a cutting-edge and rapidly scalable global enterprise, which will make a huge positive impact by uplifting the lives of millions of people
We’ve recently won an Innovate UK grant that will enable us to complete UpLift, and show its effectiveness and cost-effectiveness in 2 RCTs. We’ve also completed UpLift4Work and shown its effectiveness to reduce burnout and improve wellbeing in 2 RCTs. We’re now looking to raise funds to accelerate development, marketing and roll-out of the UpLift4Work, and prepare our solutions for other countries.
We believe that MindLife has the potential to become a unicorn and that investors who join at this stage will benefit greatly from this opportunity.